Faculty profile

Pishoy Gouda

Back to faculty

Assistant ProfessorMedicine DeptUniversity of Alberta

Pishoy Gouda

Assistant Professor

Medicine Dept

Faculty of Medicine & Dentistry

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
37 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

284

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Alberta profile.

Latest papers

Patient-Centered Evaluation of Anticoagulation in Atrial Fibrillation.
2026
Author Corrections to: “Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive [Canadian Journal of Cardiology, Volume 40, Issue 4, Pages 500-523, DOI: 10.1016/j.cjca.2023.09.033]”
Canadian Journal of Cardiology · 2026
Erratum to Author Corrections to: “Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive [Canadian Journal of Cardiology, Volume 40, Issue 4 500-523, DOI: 10.1016/j.cjca.2023.09.033]”
Canadian Journal of Cardiology · 2026

All 54 publications

54 publications.

Patient-Centered Evaluation of Anticoagulation in Atrial Fibrillation.

Shoji S, Gouda P, Falvey CA, Barnhart H, Cyr DD, Mentz RJ, Piccini JP, Patel MR, Jones WS, Kittipibul V

20262 citations

DOI: 10.1056/evidoa2500323

Author Corrections to: “Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive [Canadian Journal of Cardiology, Volume 40, Issue 4, Pages 500-523, DOI: 10.1016/j.cjca.2023.09.033]”

Guerra PG, Simpson CS, Van Spall HGC, Asgar AW, Billia P, Cadrin-Tourigny J, Chakrabarti S, Cheung CC, Dore A, Fordyce CB

Canadian Journal of Cardiology2026Open Access

DOI: 10.1016/j.cjca.2026.02.045

Erratum to Author Corrections to: “Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive [Canadian Journal of Cardiology, Volume 40, Issue 4 500-523, DOI: 10.1016/j.cjca.2023.09.033]”

Co-chairs:, Guerra PG, Simpson CS, Van Spall HGC, Panel: W, Asgar AW, Billia P, Cadrin-Tourigny J, Chakrabarti S, Cheung CC

Canadian Journal of Cardiology2026

DOI: 10.1016/j.cjca.2026.07.005

Utility of biomarkers in patients with a type 2 myocardial infarction: a systematic review.

Gouda P, Lalani S, Newby K, Lopes R, Jones S

Open heart2026First author

DOI: 10.1136/openhrt-2025-003867 PMID: 41500560

Evaluation, treatment, and outcomes in patients with possible severe aortic stenosis.

Gouda P, Cyr DD, Chiswell K, Mercer J, Hofmann P, Khan S, Vemulapalli S

American heart journal2026First author

DOI: 10.1016/j.ahj.2026.107498 PMID: 42219050

Clinical Patterns and Appropriateness of Apixaban Dosing in Patients With Atrial Fibrillation.

Gouda P, Harrington J, Arps K, Sanders G, Chen A, Chiswell K, Hofmann P, Marsolo K, Asfaw K, Coppolecchia R, Alexander JH, Piccini J, Granger CB, May HT, Chrischilles E, Steinberg BA, Chamberlain AM, VanWormer J, Jones WS, Patel MR

JACC. Advances2026First author

DOI: 10.1016/j.jacadv.2026.102954 PMID: 42372348

Messaging Modality and Content for Recruitment of Research Participants: A Randomized Clinical Trial.

Gouda P, Glover L, Kenjale A, Chiswell K, Erickson T, Goldstein B, Kelsey M, Roberts J, Peterson ED, Patel M, Truskey G, Shah S, Douglas PS, Nelson AJ, J Pagidipati N

JAMA network open2026First author

DOI: 10.1001/jamanetworkopen.2026.14046 PMID: 42172031

Obesity Pharmacotherapy: An Urgent Need for Progressing Science, Access, and Equity-JACC: Advances Expert Panel.

Gouda P, Allyn N, Belin R, Borentain M, Butler J, Curtis L, George J, Hornik C, Jackman J, Jessup M, Jordan B, Kessler P, Kocsis SW, Lartey L, Luan J, Ryan D, Waldstreicher J, Jastreboff A, Pagidipati N

JACC. Advances2026First author

DOI: 10.1016/j.jacadv.2026.102713 PMID: 41931082

An Analysis of Patient Recovery and Opinions on Driving Post-Transcatheter Aortic Valve Insertion (TAVI): the TAVI-D Study.

Jarvis CR, Gouda P, Ezekowitz J, Smith H, Tyrrell B, Welsh RC

CJC open2026

DOI: 10.1016/j.cjco.2025.10.011 PMID: 41766699

Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing.

Gouda P, Cohen L, Berelowitz K, Bollinger J, Bruno J, Cehelsky J, Charo RA, Harrop J, Kahn J, McGuire AL, O'Rourke P, Patel N, Patin E, Reece TL, Regenberg A, Rocha R, Webster H, Weinfurt K, Sugarman J, Hernandez AF

Human gene therapy2026First author

DOI: 10.1177/10430342261430765 PMID: 41902627

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Pishoy Gouda

Research

Latest papers

Patient-Centered Evaluation of Anticoagulation in Atrial Fibrillation.

Author Corrections to: “Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive [Canadian Journal of Cardiology, Volume 40, Issue 4, Pages 500-523, DOI: 10.1016/j.cjca.2023.09.033]”

Erratum to Author Corrections to: “Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive [Canadian Journal of Cardiology, Volume 40, Issue 4 500-523, DOI: 10.1016/j.cjca.2023.09.033]”

Utility of biomarkers in patients with a type 2 myocardial infarction: a systematic review.

Evaluation, treatment, and outcomes in patients with possible severe aortic stenosis.

Clinical Patterns and Appropriateness of Apixaban Dosing in Patients With Atrial Fibrillation.

Messaging Modality and Content for Recruitment of Research Participants: A Randomized Clinical Trial.

Obesity Pharmacotherapy: An Urgent Need for Progressing Science, Access, and Equity-JACC: Advances Expert Panel.

An Analysis of Patient Recovery and Opinions on Driving Post-Transcatheter Aortic Valve Insertion (TAVI): the TAVI-D Study.

Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing.

Frequent collaborators

Justin Ezekowitz

Michelle Graham

Harriette Van Spall

Candice Silversides

Padma Kaul

Susanna Mak

Andrew Krahn

Robert Sheldon

John Sapp

Colleen Norris

Finlay McAlister

Christopher Fordyce

Abhinav Sharma

Janek Senaratne

Craig Butler

Michael McGillion

John Eikelboom

Varinder Randhawa

Roopinder Sandhu

Julia Cadrin-Tourigny

Christian Steinberg

Richard Hegele

Arjun Gupta

Shaun Goodman

Steven Meyer

Michael Tsoukas

Tricia Peters

Jason Dyck

Kevin Bainey